psma-trt, 225ac-j591 and 177lu-psma i&t in mcrpc
Published 1 year ago • 271 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
1:35
vision: safety analysis of 177lu-psma-617 in mcrpc
-
1:38
177lu-psma i&t for patients with psma-positive mcrpc
-
4:48
vision: lu-177-psma-617 in mcrpc
-
3:56
vision: 177lu-psma-617 in psma-positive mcrpc
-
0:57
real-world outcomes of 177lu-psma-617 in mcrpc
-
7:52
does high psa levels = prostate cancer? | dr steven tucker
-
3:13
what is it like to have a pet scan? | cancer research uk
-
11:49
lutetium-177 (pluvicto) vs. psma-actinium | #markscholzmd #alexscholz #pcri
-
1:28
vision: 177lu-psma-617 in psma-positive mcrpc
-
1:08
psma imaging pre- and post-177lu-psma-617 treatment in mcrpc
-
5:47
phase i/ii dose-escalation study of 225ac-j591 in progressive mcrpc
-
5:27
177lu-psma-617 radionuclide therapy in mcrpc
-
3:03
vision: tolerability of 177lu-psma-617 by treatment exposure in patients with mcrpc
-
1:00
is there are role for 177lu-psma-617 in earlier lines of treatment for mcrpc?
-
5:30
fractionated dose 177lu-psma-617 in patients with mcrpc
-
3:02
unanswered questions in psma-targeted radionuclide therapy
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
5:37
177lu-psma-617 for the early treatment of prostate cancer
-
1:37
recent advances in mhspc: 177lu-psma-617, propel and biomarker-directed strategies
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc
-
3:01
preliminary findings in mcrpc for fractionated dose 177lu-psma-617
-
1:46
long term aes in psma-trt